Atara Biotherapeutics, Inc. (ATRA)
$9.38-1.05%Close
SELLRECOVERY · day 7
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $85M
- Beta
- 0.09
- P/E (TTM)
- -8.26
- Short % float
- 5.36%
- Days to cover
- 8.1
- SI change
- -20.4%
- 1W
- -0.21%
- 1M
- +0.00%
- vs SPY 1W
- -0.63%
- vs SPY 1M
- -2.06%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ATRA?
- LOPJLB’s latest quantitative signal on Atara Biotherapeutics, Inc. (ATRA) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is ATRA in?
- Atara Biotherapeutics, Inc. (ATRA) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Atara Biotherapeutics, Inc. (ATRA) do?
- Founded in 2012 and headquartered in South San Francisco, California, Atara Biotherapeutics, Inc. is dedicated to pioneering ready-to-use (off-the-shelf) T-cell immunotherapies. Their primary focus in the United States involves creating treatments for patients battling cancer, autoimmune disorders, and viral infections. A key therapeutic candidate, tabelecleucel, is currently undergoing Phase 3…